Samsung Biologics Q4 Operating Profit 92.6 Billion KRW...13.5% Decrease YoY
[Asia Economy Reporter Park Jihwan] Samsung Biologics announced on the 26th that it recorded an operating profit of 92.6 billion KRW in the fourth quarter of last year. This represents a 13.45% decrease compared to the previous year.
Hot Picks Today
!["Rather Than Endure a 1.5 Million KRW Stipend, I'd Rather Earn 500 Million in the U.S." Top Talent from SNU and KAIST Are Leaving [Scientists Are Disappearing] ①](https://cwcontent.asiae.co.kr/asiaresize/93/2026051414165763158_1778735817.jpg)
"Rather Than Endure a 1.5 Million KRW Stipend, I'd Rather Earn 500 Million in the U.S." Top Talent from SNU and KAIST Are Leaving [Scientists Are Disappearing] ①
- "Bought for a Special Price, but Cheaper Today"... Online Malls Caught Inflating Discount Rates by Raising Regular Prices
- "If That's the Case, Why Not Just Buy Stocks?" ETFs in Name Only, Now 'Semiconductor-Heavy' and a Playground for Short-Term Traders
- Singer Kim Minjong Responds to MC Mong's Gambling Allegations: "Clearly False... Legal Action to Follow"
- "No Cure Available, Spread Accelerates... Already 105 Dead, American Infected"
During the same period, sales increased by 19.78% year-on-year to 375.3 billion KRW.
This content was produced with the assistance of AI translation services.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
![Cheaper Than Mychew, but Nowhere to Be Found... Fears of a 'Pediatric Medical Crisis' as Drug Makers Halt Production [Why&Next]](https://cwcontent.asiae.co.kr/asiaresize/307/2026051910065268365_1779152813.jpg)
